[1]
Drent, M. et al. 2016. Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 33, 2 (Aug. 2016), 191–194.